Platelet-Rich Fibrin versus Allogeneic Bone Grafts in stability of one stage implant placement

Comparison between sinus augmentation with Platelet-Rich Fibrin versus Allogeneic Bone Grafts in stability of one stage implant placement

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191204045602N2

Enrollment

Registered

2020-10-27

Start date

2019-06-08

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Implant stability measurement.

Interventions

Intervention 1: Intervention group:Patients receive 2 grams of amoxicillin prophylactically one hour before surgery. After injection of Local anesthesia , a crystal incision is placed with an anterior

Eligibility

Sex/Gender

All

Age

30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients who need bilateral sinus augmentation patients with adequate interocclusal and mesiodistal distance for implant placement adequate width for implant placement 5 mm residual bone in each side

Exclusion criteria

Exclusion criteria: diabetic patients patients with history of bone grafts immunosupressive patients and corticosteroid users patients with history of chemotherapy or radiotherapy

Design outcomes

Primary

Measure	Time frame
Stability. Timepoint: Immediately after surgery and 2, 4 and 6 months later. Method of measurement: Stability: With ostell device, the degree of stability (ISQ) is measured based on resonance frequency analysis.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactaida karagah

Qazvin University of Medical Sciences

Aida_karagah@yahoo.com+98 28 3323 9252

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026